Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Its Enantiomers in Mice: Pharmacokinetic Considerations

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2009-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/jpet.109.150573PMID 19276400PMCID PMC2683777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non-linear Pharmacokinetics of MDMA ( “ Ecstasy ” ) and its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA that Develop After Typical Psychoactive Doses

  2008cited by this paper
• Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

  2008cited by this paper
• Nonlinear Pharmacokinetics of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) and Its Major Metabolites in Squirrel Monkeys at Plasma Concentrations of MDMA That Develop After Typical Psychoactive Doses

  2008cited by this paper
• MDMA (N-methyl-3,4-methylenedioxyamphetamine) and its stereoisomers: Similarities and differences in behavioral effects in an automated activity apparatus in mice.

  2008cited by this paper
• MDMA-like behavioral effects of N-substituted piperazines in the mouse.

  2007cited by this paper
• Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.

  2006cited by this paper
• Pharmacokinetic Profile of Single and Repeated Oral Doses of MDMA in Squirrel Monkeys: Relationship to Lasting Effects on Brain Serotonin Neurons

  2006cited by this paper
• Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone

  2006cited by this paper
• Interaction of Amphetamines and Related Compounds at the Vesicular Monoamine Transporter

  2006cited by this paper
• Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse

  2005cited by this paper
• Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine

  2005cited by this paper
• S(+)- and R(-)N-methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) as discriminative stimuli: effect of cocaine.

  2005cited by this paper
• Drug discrimination studies with MDMA and amphetamine

  2004cited by this paper
• Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

  2003cited by this paper
• Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites by gas chromatography/mass spectrometry.

  2003influential reference
• The content of ecstasy tablets: implications for the study of their long-term effects.

  2002cited by this paper
• Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.

  2000cited by this paper
• A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats.

  2000cited by this paper
• Quantification of 3,4-methylenedioxymetamphetamine and its metabolites in plasma and urine by gas chromatography with nitrogen-phosphorus detection.

  1999cited by this paper
• Intellectual property and chirality of drugs.

  1999cited by this paper
• Structure/activity relationships

  1998cited by this paper
• Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites.

  1998cited by this paper
• Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion.

  1996cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Institute of Laboratory Animal Resources.

  1995cited by this paper
• Stereoselective disposition: enantioselective quantitation of 3,4-(methylenedioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry.

  1993cited by this paper
• Structure‐Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Drugs? a

  1990cited by this paper
• Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships.

  1989cited by this paper
• Determination of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine enantiomers in whole blood.

  1989cited by this paper
• Stimulus properties of hallucinogenic phenalkylamines and related designer drugs: formulation of structure-activity relationships.

  1989cited by this paper
• MDMA as a discriminative stimulus: isomeric comparisons.

  1987cited by this paper
• The effect of MDMA ("Ecstasy") and its optical isomers on schedule-controlled responding in mice.

  1987cited by this paper
• Discriminative stimulus properties of (+/-)-3,4-methylenedioxymethamphetamine and (+/-)-3,4-methylenedioxyamphetamine in pigeons.

  1986cited by this paper
• The effects of (+/-)-methylenedioxymethamphetamine and (+/-)-methylenedioxyamphetamine in monkeys trained to discriminate (+)-amphetamine from saline.

  1986cited by this paper
• Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.

  1986cited by this paper
• Structure-activity relationships and mechanism of action of hallucinogenic agents based on drug discrimination and radioligand binding studies.

  1986cited by this paper
• Discriminative stimulus properties of MDA analogs.

  1982cited by this paper
• The Auditory Masking of One Pure Tone by Another and its Probable Relation to the Dynamics of the Inner Ear

  1924cited by this paper

• Derivatization-free determination of chiral plasma pharmacokinetics of MDMA and its enantiomers.

  2024cites this paper
• Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization

  2019cites this paper
• Of mice and men on MDMA: a translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine ('Ecstasy').

  2019cites this paper
• Stereoselective effects of the second-generation synthetic cathinone α-pyrrolidinopentiophenone (α-PVP): assessments of conditioned taste avoidance in rats

  2018cites this paper
• Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.

  2018cites this paper
• Discriminative Stimulus Effects of Psychostimulants.

  2018cites this paper
• In Vitro and In Vivo Characterization of the Alkaloid Nuciferine

  2016cites this paper
• What does it feel like to be a bat? Searching for ways to investigate conscious emotion in non-human animals

  2016cites this paper
• Stereoselective Effects of Abused “Bath Salt” Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation

  2016cites this paper
• Nonhuman Primate Self-Administration in Assessments of Abuse Potential

  2015cites this paper
• Baths Salts, Spice, and Related Designer Drugs: The Science Behind the Headlines

  2014cites this paper
• Looking for prosocial genes: ITRAQ analysis of proteins involved in MDMA-induced sociability in mice.

  2014cites this paper
• In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection.

  2014cites this paper
• Chiral separation of 3,4-methylenedioxymethamphetamine (MDMA) enantiomers using batch chromatography with peak shaving recycling and its effects on oxidative stress status in rat liver.

  2013cites this paper
• Microglial and astroglial activation by 3,4‐methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility

  2013cites this paper
• In vivo Effects of Abused ‘Bath Salt’ Constituent 3,4-methylenedioxypyrovalerone (MDPV) in Mice: Drug Discrimination, Thermoregulation, and Locomotor Activity

  2013cites this paper
• Modulatory effects of low-dose MDMA on cocaine-induced locomotor activity and place conditioning in rats.

  2012cites this paper
• A convenient biomimetic synthesis of optically active putative neurotoxic metabolites of MDMA ("ecstasy") from R-(-)- and S-(+)-N-methyl-α-methyldopamine precursors.

  2012cites this paper
• Effects of MDMA and related analogs on plasma 5-HT: relevance to 5-HT transporters in blood and brain.

  2012cites this paper
• (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice.

  2011cites this paper
• Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys

  2010cites this paper
• PRECLINICAL STUDY: Atypical development of behavioural sensitization to 3,4‐methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in adolescent rats and its expression in adulthood: role of the MDMA chirality

  2010cites this paper
• Synthesis and in vitro cytotoxicity profile of the R-enantiomer of 3,4-dihydroxymethamphetamine (R-(-)-HHMA): comparison with related catecholamines.

  2010cites this paper
• Discriminative Stimulus Effects of Psychostimulants and Hallucinogens in S(+)-3,4-Methylenedioxymethamphetamine (MDMA) and R(−)-MDMA Trained Mice

  2009influential citation